Galactomannan on the stage: Prospective evaluation of the applicability in routine practice and surveillance

Mycoses

Volumn 53, Issue 1, 2010, Pages 16-25

  Tanriover, Mine Durusu ^a   Ascioglu, Sibel ^a   Altun, Belgin ^a   Uzun, Omrum ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Aspergillus; Galactomannan; Invasive aspergillosis; Sensitivity; Specificity

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN B; CEFEPIME; GALACTOMANNAN; ITRACONAZOLE; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN;

ADOLESCENT; ADULT; AGED; ARTICLE; ASPERGILLOSIS; BLOOD SAMPLING; CLINICAL EVALUATION; DIAGNOSTIC ACCURACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HEALTH SURVEY; HEMATOLOGIC DISEASE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INTERNAL MEDICINE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; VITAL SIGN;

ADOLESCENT; ADULT; AGED; ANTIGENS, FUNGAL; ASPERGILLOSIS; CLINICAL LABORATORY TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MANNANS; MIDDLE AGED; POPULATION SURVEILLANCE; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

ASPERGILLUS;

EID: 72349088189     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2008.01652.x     Document Type: Article

References (46)

1. Marino IR, Panarello G, Singh N. Efficacy of Aspergillus galactomannan-directed preemptive therapy for the prevention of invasive aspergillosis in organ transplant recipients. Transpl Infect Dis 2002 4 : 226 227.
2. Erjavec Z, Verweij PE. Recent progress in the diagnosis of fungal infections in the immunocompromised host. Drug Resist Updat 2002 5 : 3 10.
3. Stevens DA. Diagnosis of fungal infections: current status. J Antimicrob Chemother 2002 49 (Suppl. s1 11 9.
4. Caillot D, Couaillier JF, Bernard A et al. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol 2001 19 : 253 259.
5. Hauggaard A, Ellis M, Ekelund L. Early chest radiography and CT in the diagnosis, management and outcome of invasive pulmonary asprgillosis. Acta Radiol 2002 43 : 292 298.
6. Greene R. The radiological spectrum of pulmonary aspergillosis. Med Mycol 2005 43 (Suppl. 1 S147 54.
7. Weisser M, Rausch C, Droll A et al. Galactomannan does not precede major signs on a pulmonary computerized tomographic scan suggestive of invasive aspergillosis in patients with hematological malignancies. Clin Infect Dis 2005 41 : 1143 1149.
8. Bernard M, Latge JP. Aspergillus fumigatus cell wall: composition and biosynthesis. Med Mycol 2001 39 (Suppl. 1 9 17.
9. Verweij PE, Stynen D, Rijs AJ, de Pauw BE, Hoogkamp-Korstanje JA, Meis JF. Sandwich enzyme-linked immunosorbent assay compared with Pastorex latex agglutination test for diagnosing invasive aspergillosis in immunocompromised patients. J Clin Microbiol 1995 33 : 1912 1914.
10. Stynen D, Goris A, Sarfati J, Latge JP. A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis. J Clin Microbiol 1995 33 : 497 500.
11. Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999 12 : 310 350.
12. Maertens J, Verhaegen J, Lagrou K, Van Eldere J, Boogaerts M. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 2001 97 : 1604 1610.
13. Maertens J, Verhaegen J, Demuynck H et al. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive Aspergillosis. J Clin Microbiol 1999 37 : 3223 3228.
14. Pinel C, Fricker-Hidalgo H, Lebeau B et al. Detection of circulating Aspergillus fumigatus galactomannan: value and limits of the Platelia test for diagnosing invasive aspergillosis. J Clin Microbiol 2003 41 : 2184 2186.
15. Sulahian A, Tabouret M, Ribaud P et al. Comparison of an enzyme immunoassay and latex agglutination test for detection of galactomannan in the diagnosis of invasive aspergillosis. Eur J Clin Microbiol Infect Dis 1996 15 : 139 145.
16. Buchheidt D, Hummel M, Schleiermacher D et al. Prospective clinical evaluation of a LightCycler-mediated polymerase chain reaction assay, a nested-PCR assay and a galactomannan enzyme-linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and haematological stem cell transplant recipients. Br J Haematol 2004 125 : 196 202.
17. Marr KA, Balajee SA, McLaughlin L, Tabouret M, Bentsen C, Walsh TJ. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J Infect Dis 2004 190 : 641 649.
18. Becker MJ, Lugtenburg EJ, Cornelissen JJ, Van Der Schee C, Hoogsteden HC, De Marie S. Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis. Br J Haematol 2003 121 : 448 457.
19. Allan EK, Jordanides NE, McLintock LA et al. Poor performance of galactomannan and mannan sandwich enzyme-linked immunosorbent assays in the diagnosis of invasive fungal infection. Br J Haematol 2005 128 : 578 579.
20. Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis 2006 42 : 1417 1427.
21. Kawazu M, Kanda Y, Nannya Y et al. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1→3)-β-d-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders. J Clin Microbiol 2004 42 : 2733 2741.
22. Maertens J, Theunissen K, Verbeken E et al. Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients. Br J Haematol 2004 126 : 852 860.
23. Verweij PE, Erjavec Z, Sluiters W et al. Detection of antigen in sera of patients with invasive aspergillosis: intra- and interlaboratory reproducibility. The Dutch Interuniversity Working Party for Invasive Mycoses. J Clin Microbiol 1998 36 : 1612 1616.
24. Wheat LJ. Rapid diagnosis of invasive aspergillosis by antigen detection. Transpl Infect Dis 2003 5 : 158 166.
25. Mennink-Kersten MASH, Donnelly JP, Verweij PE. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis 2004 4 : 349 357.
26. Maertens JA, Klont R, Masson C et al. Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay. Clin Infect Dis 2007 44 : 1329 1336.
27. Ascioglu S, Rex JH, Pauw B et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants. An international consensus. Clin Infect Dis 2002 34 : 7 14.
28. Costa C, Costa JM, Desterke C, Botterel F, Cordonnier C, Bretagne S. Real-time PCR coupled with automated DNA extraction and detection of galactomannan antigen in serum by enzyme-linked immunosorbent assay for diagnosis of invasive aspergillosis. J Clin Microbiol 2002 40 : 2224 2227.
29. Bretagne S, Costa JM, Bart-Delabesse E, Dhédin N, Rieux C, Cordonnier C. Comparison of serum galactomannan antigen detection and competitive polymerase chain reaction for diagnosing invasive aspergillosis. Clin Infect Dis 1998 26 : 1407 1412.
30. Bretagne S, Marmorat-Khuong A, Kuentz M, Latgé JP, Bart-Delabesse E, Cordonnier C. Serum Aspergillus galactomannan antigen testing by sandwich ELISA: practical use in neutropenic patients. J Infect 1997 35 : 7 15.
31. Maertens J, Van Eldere J, Verhaegen J, Verbeken E, Verschakelen J, Boogaerts M. Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. J Infect Dis 2002 186 : 1297 1306.
32. Maertens J, Theunissen K, Verhoef G et al. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clin Infect Dis 2005 41 : 1242 1250.
33. Florent M, Katsahian S, Vekhoff A et al. Prospective evaluation of a polymerase chain reaction-ELISA targeted to Aspergillus fumigatus and Aspergillus flavus for the early diagnosis of invasive aspergillosis in patients with hematological malignancies. J Infect Dis 2006 193 : 741 747.
34. White PL, Linton CJ, Perry MD, Johnson EM, Barnes RA. The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting. Clin Infect Dis 2006 42 : 479 486.
35. Adam O, Auperin A, Wilquin F, Bourhis JH, Gachot B, Chachaty E. Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannnan antigen test result with hematological malignancies. Clin Infect Dis 2004 38 : 917 920.
36. Tanriover MD, Metan G, Altun B, Hascelik G, Uzun O. False positivity for Aspergillus antigenemia related to the administration of piperacillin/ tazobactam. Eur J Intern Med 2005 16 : 489 491. (Pubitemid 41597055)
37. Kawamura S, Maesaki S, Noda T et al. Comparison between PCR and detection of antigen in sera for diagnosis of pulmonary aspergillosis. J Clin Microbiol 1999 37 : 218 220.
38. Sulahian A, Touratier S, Ribaud P. False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. N Engl J Med 2003 349 : 2366 2367.
39. Viscoli C, Machetti M, Cappellano P et al. False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin- tazobactam. Clin Infect Dis 2004 38 : 913 916.
40. Wheat LJ, Hackett E, Durkin M et al. Histoplasmosis-associated cross-reactivity in the BioRad Platelia Aspergillus enzyme immunoassay. Clin Vaccine Immunol 2007 14 : 638 640.
41. Dalle F, Charles PE, Blanc K et al. Cryptococcus neoformans galactoxylomannan contains an epitope(s) that is cross-reactive with Aspergillus galactomannan. J Clin Microbiol 2005 43 : 2929 2931.
42. Huang YT, Hung CC, Liao CH, Sun HY, Chang SC, Chen YC. Detection of circulating galactomannan in Penicillium marneffei infection and cryptococcosis among patients infected with human immnunodeficiency virus. J Clin Microbiol 2007 49 : 2858 2862.
43. Cummings JR, Jamison GR, Boudreaux JW, Howles MJ, Walsh TJ, Hayden RT. Cross-reactivity of non-Aspergillus fungal species in the Aspergillus galactomannan enzyme immunoassay. Diagn Microbiol Infect Dis 2007 59 : 113 115.
44. Kappe R, Schulze-Berge A. New cause for false-positive results with the Pastorex Aspergillus antigen latex agglutination test. J Clin Microbiol 1993 31 : 2489 2490.
45. Ansorg R, Boom R, Rath PM. Detection of galactomannan antigen in foods and antibiotics. Mycoses 1997 40 : 353 357.
46. Subirà M, Martino R, Rovira M, Vazquez L, Serrano D, De La Cámara R. Clinical applicability of the new EORTC/MSG classification for invasive pulmonary aspergillosis in patients with hematological malignancies and autopsy-confirmed invasive aspergillosis. Ann Hematol 2003 82 : 80 2.